Literature DB >> 23266468

Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside.

K Gariani1, J Philippe, F R Jornayvaz.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is now the most frequent chronic liver disease in the developed countries. There is also growing evidence from basic and clinical research that NAFLD has a strong relationship to insulin resistance, which is a key factor in the development of type 2 diabetes. The aim of this review is to summarize the recent important findings linking NAFLD and insulin resistance. Lipid accumulation, particularly of diacylglycerol, appears to be of major importance in this process. Mitochondrial dysfunction, through decreased mitochondrial biogenesis, increases oxidative stress, and ageing also plays an important role. Finally, endoplasmic reticulum stress and inflammation also probably contribute to the development of insulin resistance via mechanisms that are still not well understood. Clinical aspects of NAFLD, such as its diagnosis and management, are also investigated in this review.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23266468     DOI: 10.1016/j.diabet.2012.11.002

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  39 in total

Review 1.  Non-alcoholic fatty liver disease: The diagnosis and management.

Authors:  Shehab M Abd El-Kader; Eman M Salah El-Den Ashmawy
Journal:  World J Hepatol       Date:  2015-04-28

2.  Ablating both Fabp1 and Scp2/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice.

Authors:  Sherrelle Milligan; Gregory G Martin; Danilo Landrock; Avery L McIntosh; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-01-04       Impact factor: 4.698

3.  Excess vitamin intake: An unrecognized risk factor for obesity.

Authors:  Shi-Sheng Zhou; Yiming Zhou
Journal:  World J Diabetes       Date:  2014-02-15

4.  p110α Hot Spot Mutations E545K and H1047R Exert Metabolic Reprogramming Independently of p110α Kinase Activity.

Authors:  Aditi Chaudhari; Daniel Krumlinde; Annika Lundqvist; Levent M Akyürek; Sashidhar Bandaru; Kristina Skålén; Marcus Ståhlman; Jan Borén; Yvonne Wettergren; Katarina Ejeskär; Victoria Rotter Sopasakis
Journal:  Mol Cell Biol       Date:  2015-07-13       Impact factor: 4.272

5.  Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis.

Authors:  Varun Chandrashekaran; Suvarthi Das; Ratanesh Kumar Seth; Diptadip Dattaroy; Firas Alhasson; Gregory Michelotti; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Biochim Biophys Acta       Date:  2015-10-22

6.  SphK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes.

Authors:  Tuoyu Geng; Alton Sutter; Michael D Harland; Brittany A Law; Jessica S Ross; David Lewin; Arun Palanisamy; Sarah B Russo; Kenneth D Chavin; L Ashley Cowart
Journal:  J Lipid Res       Date:  2015-10-19       Impact factor: 5.922

7.  Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea.

Authors:  Young Eun Chon; Kyu Sik Jung; Kwang Joon Kim; Dong Jin Joo; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Seung Up Kim
Journal:  Dig Dis Sci       Date:  2014-08-14       Impact factor: 3.199

8.  Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice.

Authors:  Yasodha Krishnasamy; Monika Gooz; Li Li; John J Lemasters; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2019-10-15

Review 9.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

10.  Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-α activation in cultured human female hepatocytes.

Authors:  Avery L McIntosh; Huan Huang; Stephen M Storey; Kerstin K Landrock; Danilo Landrock; Anca D Petrescu; Shipra Gupta; Barbara P Atshaves; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-29       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.